BioWorld

June 17, 2002

Money Raised Year To Date

Stock Winners and Losers For The Week

Clinical Trial Update: May 2002

Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: May 2002

FDA Submissions, Approvals And Other Actions: May 2002

Biotech Dream Of Going Global Attainable With Capital, Products

Every start-up biotech company dreams about breakthrough product approvals, positive cash flows and becoming global. (BioWorld Financial Watch) Read More

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for June 18, 2025.

An early stage 85% remissions rate in AML drives Aptevo’s stock surge

BioWorld

An 85% remissions rate was found in updated results from Aptevo Therapeutics Inc.’s ongoing phase Ib/II Ranier study of mipletamig in one of the toughest blood...

BIO 2025: Makary lays out FDA’s path, launches pilot review program

BioWorld

On the same day that FDA Commissioner Martin Makary spoke in a fireside chat during the 2025 Biotechnology Innovation Organization’s International Convention, the...

3D illustration of a chain of amino acid or biomolecules called protein

Alphadesign: AI creating proteins from scratch

BioWorld Science

The Alphafold machine learning system for predicting a protein’s structure from its amino acid sequence has been adapted to make it possible to design de novo...